6 Apr 2013: AACR: Development of a HER2-based GEDI microfluidic device for the molecular characterization of CTCs from metastatic breast cancer patients

• 11 years ago
• Posted in:Uncategorized
• 0
• Author: Brian Kirby
• Tags: 2013, bk88, ctc, LOC, micronano, pres

Galletti GI , Kirby BJ , Vahdat LT , Giannakakou PA, Development of a HER2-based GEDI microfluidic device for the molecular characterization of CTCs from metastatic breast cancer patients, AACR 2013, Washington, DC.